Repricing Analysis

Where has your plan been overspending on high-cost pharmacy claims?

A Repricing Analysis is a structured review designed to help plans understand where containment opportunities may — or may not — exist, without disrupting existing PBM, TPA, broker, or stop-loss relationships.

Actuarially Certified

Validated. Certified. Proven.

NIH’s Repricing Analysis methodology and savings results are independently reviewed and actuarially certified by leading stop-loss carriers and managing general underwriters — the same partners your plan already relies on for catastrophic claims protection.

That certification typically translates into renewal discounts of 5–10% on stop-loss premium, stacking measurable underwriting value on top of the pharmacy savings NIH helps surface.

Request form

See What Your Claims Should Be Costing

Required fields are marked with an asterisk. NIH will follow up to scope a free Repricing Analysis based on the details you share.

Important
Do not submit protected health information (PHI), member names, prescription details, diagnosis information, or claims files through this form. If claims data is needed, NIH will provide a separate secure intake process.

Important
Do not submit protected health information (PHI), member names, prescription details, diagnosis information, or claims files through this form. If claims data is needed, NIH will provide a separate secure intake process.